Vioxx Lawsuits Resources

Vioxx Off-Label Marketing To Cost Merck $321 Million
Vioxx off-label marketing activities are going to cost Merck & Co. a whopping $321 million in criminal fines. The U.S. Food & Drug Administration (FDA) approved Vioxx (rofecoxib), a painkiller, for three indications in May 1999. Merck has pleaded guilty … Continue reading →

Bernstein Liebhard Partner Jeffrey S. Grand Appointed To Plaintiffs’ Steering Committee In Transvaginal Mesh MDLs
Bernstein Liebhard LLP is pleased to announce that on April 13, 2012 partner Jeffrey S. Grand was appointed to the Plaintiffs’ Steering Committee in four transvaginal mesh MDLs against manufacturers of vaginal mesh implants.New York, New York (PRWEB) April 25, 2012 Bernstein Liebhard LLP is pleased to announce that on April 13, 2012 partner Jeffrey S. Grand was named to the Plaintiffs’ Steering ...

Seven days: 20-26 April 2012
The week in science: Roche drops pursuit of Illumina; UN ecosystems panel launches; and a venture to mine asteroids launches.

Drug Safety Tracked Even After Approval, FDA Says
* Agency has required 385 postmarket studies since 2008 * New safety information led to changed labels 65 times By Debra Sherman ATLANTA, April 21 (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.

Chinas Luftfahrt Flügel verleihen
China baut sein erstes Mittelstreckenflugzeug. Der Hartschaumstoff Rohacell von Evonik sorgt dabei...